First Time Loading...

Replimune Group Inc
NASDAQ:REPL

Watchlist Manager
Replimune Group Inc Logo
Replimune Group Inc
NASDAQ:REPL
Watchlist
Price: 6.58 USD 2.49% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

REPL Price Targets Summary
Replimune Group Inc

Wall Street analysts forecast REPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REPL is 13.83 USD with a low forecast of 10.1 USD and a high forecast of 19.95 USD.

Lowest
Price Target
10.1 USD
53% Upside
Average
Price Target
13.83 USD
110% Upside
Highest
Price Target
19.95 USD
203% Upside
Replimune Group Inc Competitors:
Price Targets
IVA
Inventiva SA
277% Upside
086890
Isu Abxis Co Ltd
123% Upside
603387
Getein Biotech Inc
306% Upside
300439
MedicalSystem Biotechnology Co Ltd
143% Upside
CDMO
Avid Bioservices Inc
65% Upside
ARQT
Arcutis Biotherapeutics Inc
109% Upside
SPRO
Spero Therapeutics Inc
431% Upside
ALERS
Eurobio Scientific SA
108% Upside

Revenue
Forecast

Revenue Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REPL's stock price target?
Price Target
13.83 USD

According to Wall Street analysts, the average 1-year price target for REPL is 13.83 USD with a low forecast of 10.1 USD and a high forecast of 19.95 USD.